Immunology Research
Click the below button to learn more about our autoimmune disease research and clinical trials.
Learn MoreThe main purpose of this study is to assess the efficacy and safety of LY3361237 in participants with at least moderately active systemic lupus erythematosus (SLE).
Participants must have systemic lupus erythematosus at least for the last 24 weeks
Participants must be receiving NSAID, antimalarial, steroids or medications that reduce strength of body's immune response
Participants must not have been taking oral steroids at more than 20 milligrams daily
Participants must not have an active infection at least for the last 30 days
Participants must not have hepatitis B or hepatitis C, human immunodeficiency virus (HIV) infection or tuberculosis (TB)
Participants must not have active fibromyalgia
Participants must not have had a unstable heart disease within the last 24 weeks
Participants must not have serious medical condition that could interfere with the analysis of the study
Participants must not have serious risk for suicide
Participants must not be pregnant or nursing
Click the below button to learn more about our autoimmune disease research and clinical trials.
Learn MoreA clinical trial is a scientific study. It helps us learn if a new medicine or treatment works and how it works. Clinical trials can also be called clinical research studies. Learn more about clinical research studies and what to expect when taking part in a clinical trial.